Author Archives: quattro-creative

Nov. 2019 | Poxel obtains additional funding from IPF Partners for a maximum amount of €30m

Poxel obtains additional funding from IPF Partners for a maximum amount of €30m Poxel SA, a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and non-alcoholic steatohepatitis (NASH), announced today that it has obtained additional funding in the form of a bond loan from IPF Partners, a…

Oct. 2019 | Adocia obtains additional financial resources from IPF Partners for a maximum amount of €15m

Mauna Kea Technologies (Euronext: MKEA) inventor of Cellvizio®, the multidisciplinary probe-based and needle-based confocal laser endomicroscopy (pCLE/ nCLE ) platform…

Nov. 2018 | Mauna Kea Technologies secures another €10m Senior Debt Financing with IPF Partners

Mauna Kea Technologies (Euronext: MKEA) inventor of Cellvizio®, the multidisciplinary probe-based and needle-based confocal laser endomicroscopy (pCLE/ nCLE ) platform…

June 2018 | IPF Partners Completes €20m Debt & Warrants Investment with Pharnext

Mauna Kea Technologies (Euronext: MKEA) inventor of Cellvizio®, the multidisciplinary probe-based and needle-based confocal laser endomicroscopy (pCLE/ nCLE ) platform…

Feb. 2018 | Mainstay Medical announces €30m financing supported by new investors and IPF Partners

Mauna Kea Technologies (Euronext: MKEA) inventor of Cellvizio®, the multidisciplinary probe-based and needle-based confocal laser endomicroscopy (pCLE/ nCLE ) platform…

Feb. 2018 | IPF Partners featured in Private Debt Investor

Mauna Kea Technologies (Euronext: MKEA) inventor of Cellvizio®, the multidisciplinary probe-based and needle-based confocal laser endomicroscopy (pCLE/ nCLE ) platform…

Sept. 2017 | IPF Partners Announces Successful Dry Closing of a New Debt Fund, IPF Fund II

Mauna Kea Technologies (Euronext: MKEA) inventor of Cellvizio®, the multidisciplinary probe-based and needle-based confocal laser endomicroscopy (pCLE/ nCLE ) platform…

June 2017 | IPF Partners completes €7m financing with Lumeon

Mauna Kea Technologies (Euronext: MKEA) inventor of Cellvizio®, the multidisciplinary probe-based and needle-based confocal laser endomicroscopy (pCLE/ nCLE ) platform…

April 2017 | Codman Neuro Announces Acquisition of Neuravi

Mauna Kea Technologies (Euronext: MKEA) inventor of Cellvizio®, the multidisciplinary probe-based and needle-based confocal laser endomicroscopy (pCLE/ nCLE ) platform…

Feb. 2017 | Mauna Kea Technologies secures a €7m senior Debt Financing with IPF Partners

Mauna Kea Technologies (Euronext: MKEA) inventor of Cellvizio®, the multidisciplinary probe-based and needle-based confocal laser endomicroscopy (pCLE/ nCLE ) platform…